• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER (ISRAEL) LTD. CARTO® 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER (ISRAEL) LTD. CARTO® 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE Back to Search Results
Model Number M-4800-01
Device Problem Insufficient Information (3190)
Patient Problems Dyspnea (1816); Fever (1858); Pain (1994); Swelling (2091); Cardiac Tamponade (2226); Complaint, Ill-Defined (2331); Sweating (2444); Weight Changes (2607)
Event Date 06/01/2015
Event Type  Injury  
Manufacturer Narrative
The hardware investigation has begun but it has not been completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.(b)(4) are related to the same incident.
 
Event Description
It was reported that a patient, (b)(6), male, underwent a pulmonary vein isolation (pvi) procedure with a thermocool smarttouch bi-directional navigation catheter and a carto 3 mapping system and suffered a cardiac tamponade, which required a pericardiocentesis.Ten days after the procedure, the patient was diagnosed with a late tamponade.The physician performed a pericardiocentesis on the patient.The patient fully recovered and is clinically asymptomatic.Additional information was received on the event.A transseptal puncture was performed with an unknown needle.Anticoagulation was provided to the patient and maintained at 250-300s during the procedure.After the pvi, the patient suffered from thoracic pain, subfebrility, dyspnea, coughing, fever, sweating, 8kg weight gain with swollen feet, abdomen and orthopnea.The patient did require hospitalization due to the pericardiocentesis.It is unknown when the event occurred but it is thought to have probably occurred during the ablation phase.Settings during the event include: temperature control mode / irrigation flow setting 17-30ml/min / 8f preface sheath was used.The physician's opinion regarding the cause of this adverse event is that this is procedure related as a result of excessive ablation due to the use of visitag.Since the use of visitags, physicians tend to ablate until a certain fti value is reached.This might lead to overshooting.Therefore in taking a conservative approach, this event is also be reported under both the ablation catheter and the carto 3 system.The bwi awareness date for this complaint is 9/23/2015, the date in which a bwi employee was first made aware of this adverse event.
 
Manufacturer Narrative
(b)(4) it was reported that a patient, 63 year old, male, underwent a pulmonary vein isolation (pvi) procedure with a thermocool® smarttouch® bi-directional navigation catheter and a carto 3 mapping system and suffered a cardiac tamponade, which required a pericardiocentesis.The physician¿s opinion regarding the cause of this adverse event is that this is procedure related as a result of excessive ablation due to the use of visitag.Since the use of visitags, physicians tend to ablate until a certain fti value is reached.This might lead to overshooting.Therefore in taking a conservative approach, this event was also reported under both the ablation catheter and the carto 3 system.Bwi representative informed they are not requesting the system to be checked.The system is ready for use.The history of customer complaints associated with carto 3 system # 10386 was reviewed.There were not any additional complaints that may be related to the reported issue.Device history record review was performed by the manufacturer and no anomalies were noted in manufacturing or servicing of this equipment.An internal corrective action has been opened to address this issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO® 3 SYSTEM
Type of Device
COMPUTER, DIAGNOSTIC, PROGRAMMABLE
Manufacturer (Section D)
BIOSENSE WEBSTER (ISRAEL) LTD.
4 hatnufah street
yokneam 20667 17
IS  2066717
Manufacturer (Section G)
BIOSENSE WEBSTER (ISRAEL) LTD.
4 hatnufah street
yokneam 20667 17
IS   2066717
Manufacturer Contact
joaquin kurz
9497893837
MDR Report Key5153752
MDR Text Key28454096
Report Number3008203003-2015-00084
Device Sequence Number1
Product Code DQK
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
K133916
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Followup
Report Date 09/24/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/15/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM-4800-01
Device Catalogue NumberFG540000
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received09/23/2015
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age63 YR
-
-